Skip to main content
logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
35.33
0.00 (0.00%)
Aug 26, 2026, 9:33 AM EDT - Market open

Assembly Biosciences Revenue

Assembly Biosciences had revenue of $13.37M in the quarter ending June 30, 2026, with 38.94% growth. This brings the company's revenue in the last twelve months to $74.85M, up 125.12% year-over-year. In the year 2025, Assembly Biosciences had annual revenue of $72.30M with 153.52% growth.

Revenue (ttm)
$74.85M
Revenue Growth
+125.12%
P/S Ratio
9.61
Revenue / Employee
$1,025,274
Employees
73
Market Cap
719.34M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202572.30M43.78M153.52%
Dec 31, 202428.52M21.36M298.16%
Dec 31, 20237.16M--
Dec 31, 2022---
Dec 31, 20216.25M-72.85M-92.09%
Dec 31, 202079.11M63.14M395.55%
Dec 31, 201915.96M1.16M7.83%
Dec 31, 201814.80M5.79M64.14%
Dec 31, 20179.02M--
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Phathom Pharmaceuticals239.66M
Zevra Therapeutics136.07M
Gyre Therapeutics109.82M
OmniAb38.46M
Scribe Therapeutics36.28M
CytomX Therapeutics18.30M
Crescent Biopharma11.88M
Allogene Therapeutics4.64M
Revenue Rankings

ASMB News

More News